The global exosomes market size reached USD 0.50 Billion in 2021 and is expected to register a revenue CAGR of 18% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of cancer, rapid scientific advancements in exosome research and technology development, improved exosome separation, characterization, and component detection methods, and increasing number of clinical studies and trials in the field of exosome-based research are some key factors driving market revenue growth.
The Exosomes Market report offers a comprehensive overview of the market along with details about market size, market share, revenue growth, and top companies. The report covers all crucial and essential information related to global Exosomes market to help readers, investors, clients to gain a thorough understanding of the market and invest accordingly. Various advanced statistical tools such as SWOT analysis or Porter’s Five Forces are used in the report.
Competitive Terrain:
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Exosomes market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
The leading market contenders listed in the report are:
QIAGEN, Takara Bio Company, Illumina, Inc., Thermo Fisher Scientific, Inc., Codiak Biosciences, Exosome Diagnostics, Evox Therapeutics, ExCoBio Inc., Bio-Rad Laboratories Ltd., and Beckman Coulter, Inc
Emergen Research has segmented the global Exosomes market on the basis of type, application, end-use, and region:
Segments Covered in this report are:
- Type Outlook (Revenue, USD Billion; 2019-2030)
- Biomarkers
- Drug Delivery Systems
- Vaccine Development
- Therapeutic Agents
- Others
- Product Type Outlook (Revenue, USD Billion; 2019-2030)
- Kits
- Reagents
- Instruments
- Application Outlook (Revenue, USD Billion; 2019-2030)
- Cancer
- Neurodegenerative Disease
- Cardiovascular Diseases
- Infectious Diseases
- Tissue Regeneration
- Others
The various regions analyzed in the report include:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key Objectives of the Report:
- Analysis and estimation of the Exosomes Market size and share for the projected period of 2022-2030
- Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
- Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Exosomes Market
- Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
- Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.